id	sid	tid	token	lemma	pos
dpc-4332	1	1	dermatology	dermatology	NOUN
dpc-4332	1	2	:	:	PUNCT
dpc-4332	1	3	practical	practical	ADJ
dpc-4332	1	4	and	and	CCONJ
dpc-4332	1	5	conceptual	conceptual	ADJ
dpc-4332	1	6	research	research	NOUN
dpc-4332	1	7	letter	letter	NOUN
dpc-4332	2	1	|	|	ADV
dpc-4332	2	2	dermatol	dermatol	ADJ
dpc-4332	2	3	pract	pract	NOUN
dpc-4332	2	4	concept	concept	NOUN
dpc-4332	2	5	.	.	PUNCT
dpc-4332	3	1	2024;14(4):e2024233	2024;14(4):e2024233	NUM
dpc-4332	3	2	1	1	NUM
dpc-4332	3	3	ecthyma	ecthyma	NOUN
dpc-4332	3	4	gangrenosum	gangrenosum	NOUN
dpc-4332	3	5	secondary	secondary	ADJ
dpc-4332	3	6	to	to	ADP
dpc-4332	3	7	panton	panton	PROPN
dpc-4332	3	8	-	-	PUNCT
dpc-4332	3	9	valentine	valentine	PROPN
dpc-4332	3	10	leukocidin	leukocidin	ADV
dpc-4332	3	11	–	–	PUNCT
dpc-4332	3	12	secreting	secrete	VERB
dpc-4332	3	13	staphylococcus	staphylococcus	NOUN
dpc-4332	3	14	aureus	aureus	NOUN
dpc-4332	3	15	in	in	ADP
dpc-4332	3	16	an	an	DET
dpc-4332	3	17	immunocompetent	immunocompetent	ADJ
dpc-4332	3	18	patient	patient	ADJ
dpc-4332	3	19	françois	françois	PROPN
dpc-4332	3	20	-	-	PUNCT
dpc-4332	3	21	xavier	xavier	PROPN
dpc-4332	3	22	blanchet1	blanchet1	PROPN
dpc-4332	3	23	,	,	PUNCT
dpc-4332	3	24	marion	marion	PROPN
dpc-4332	3	25	delannoy1	delannoy1	PROPN
dpc-4332	3	26	,	,	PUNCT
dpc-4332	3	27	christine	christine	PROPN
dpc-4332	3	28	forasassi1	forasassi1	PROPN
dpc-4332	3	29	,	,	PUNCT
dpc-4332	3	30	juliette	juliette	PROPN
dpc-4332	3	31	fontaine1	fontaine1	PROPN
dpc-4332	3	32	,	,	PUNCT
dpc-4332	3	33	fabienne	fabienne	PROPN
dpc-4332	3	34	carre2	carre2	PROPN
dpc-4332	3	35	,	,	PUNCT
dpc-4332	3	36	dorothée	dorothée	NOUN
dpc-4332	3	37	chopin3	chopin3	NOUN
dpc-4332	3	38	,	,	PUNCT
dpc-4332	3	39	hester	hester	VERB
dpc-4332	3	40	colboc1	colboc1	NOUN
dpc-4332	3	41	1	1	NUM
dpc-4332	3	42	department	department	NOUN
dpc-4332	3	43	of	of	ADP
dpc-4332	3	44	geriatric	geriatric	ADJ
dpc-4332	3	45	wound	wound	NOUN
dpc-4332	3	46	and	and	CCONJ
dpc-4332	3	47	healing	healing	NOUN
dpc-4332	3	48	,	,	PUNCT
dpc-4332	3	49	rothschild	rothschild	PROPN
dpc-4332	3	50	hospital	hospital	PROPN
dpc-4332	3	51	,	,	PUNCT
dpc-4332	3	52	sorbonne	sorbonne	PROPN
dpc-4332	3	53	university	university	PROPN
dpc-4332	3	54	,	,	PUNCT
dpc-4332	3	55	paris	paris	PROPN
dpc-4332	3	56	,	,	PUNCT
dpc-4332	3	57	france	france	PROPN
dpc-4332	3	58	2	2	NUM
dpc-4332	3	59	otorhinolaryngology	otorhinolaryngology	NOUN
dpc-4332	3	60	department	department	NOUN
dpc-4332	3	61	,	,	PUNCT
dpc-4332	3	62	pitié	pitié	NOUN
dpc-4332	3	63	-	-	PUNCT
dpc-4332	3	64	salpêtrière	salpêtrière	NOUN
dpc-4332	3	65	hospital	hospital	NOUN
dpc-4332	3	66	,	,	PUNCT
dpc-4332	3	67	sorbonne	sorbonne	PROPN
dpc-4332	3	68	university	university	PROPN
dpc-4332	3	69	,	,	PUNCT
dpc-4332	3	70	paris	paris	PROPN
dpc-4332	3	71	,	,	PUNCT
dpc-4332	3	72	france	france	PROPN
dpc-4332	3	73	3	3	NUM
dpc-4332	3	74	infectious	infectious	ADJ
dpc-4332	3	75	diseases	disease	NOUN
dpc-4332	3	76	department	department	NOUN
dpc-4332	3	77	,	,	PUNCT
dpc-4332	3	78	saint	saint	PROPN
dpc-4332	3	79	antoine	antoine	PROPN
dpc-4332	3	80	hospital	hospital	PROPN
dpc-4332	3	81	,	,	PUNCT
dpc-4332	3	82	sorbonne	sorbonne	PROPN
dpc-4332	3	83	university	university	PROPN
dpc-4332	3	84	,	,	PUNCT
dpc-4332	3	85	paris	paris	PROPN
dpc-4332	3	86	,	,	PUNCT
dpc-4332	3	87	france	france	PROPN
dpc-4332	3	88	key	key	ADJ
dpc-4332	3	89	words	word	NOUN
dpc-4332	3	90	:	:	PUNCT
dpc-4332	3	91	ecthyma	ecthyma	NOUN
dpc-4332	3	92	gangrenosum	gangrenosum	NOUN
dpc-4332	3	93	,	,	PUNCT
dpc-4332	3	94	methicillin	methicillin	NOUN
dpc-4332	3	95	-	-	PUNCT
dpc-4332	3	96	sensitive	sensitive	ADJ
dpc-4332	3	97	staphylococcus	staphylococcus	NOUN
dpc-4332	3	98	aureus	aureus	NOUN
dpc-4332	3	99	,	,	PUNCT
dpc-4332	3	100	panton	panton	PROPN
dpc-4332	3	101	-	-	PUNCT
dpc-4332	3	102	valentine	valentine	PROPN
dpc-4332	3	103	leukocidin	leukocidin	ADV
dpc-4332	3	104	,	,	PUNCT
dpc-4332	3	105	immunocompetent	immunocompetent	ADJ
dpc-4332	3	106	patient	patient	ADJ
dpc-4332	3	107	citation	citation	NOUN
dpc-4332	3	108	:	:	PUNCT
dpc-4332	3	109	blanchet	blanchet	PROPN
dpc-4332	3	110	fx	fx	PROPN
dpc-4332	3	111	,	,	PUNCT
dpc-4332	3	112	delannoy	delannoy	NOUN
dpc-4332	3	113	m	m	PROPN
dpc-4332	3	114	,	,	PUNCT
dpc-4332	3	115	forasassi	forasassi	PROPN
dpc-4332	3	116	c	c	NOUN
dpc-4332	3	117	,	,	PUNCT
dpc-4332	3	118	et	et	PROPN
dpc-4332	3	119	al	al	PROPN
dpc-4332	3	120	.	.	PROPN
dpc-4332	3	121	ecthyma	ecthyma	PROPN
dpc-4332	3	122	gangrenosum	gangrenosum	VERB
dpc-4332	3	123	secondary	secondary	ADJ
dpc-4332	3	124	to	to	ADP
dpc-4332	3	125	panton	panton	PROPN
dpc-4332	3	126	-	-	PUNCT
dpc-4332	3	127	valentine	valentine	PROPN
dpc-4332	3	128	leukocidin	leukocidin	ADV
dpc-4332	3	129	–	–	PUNCT
dpc-4332	3	130	secreting	secrete	VERB
dpc-4332	3	131	staphylococcus	staphylococcus	NOUN
dpc-4332	3	132	aureus	aureus	NOUN
dpc-4332	3	133	in	in	ADP
dpc-4332	3	134	an	an	DET
dpc-4332	3	135	immunocompetent	immunocompetent	ADJ
dpc-4332	3	136	patient	patient	NOUN
dpc-4332	3	137	.	.	PUNCT
dpc-4332	4	1	dermatol	dermatol	NOUN
dpc-4332	4	2	pract	pract	PROPN
dpc-4332	4	3	concept	concept	NOUN
dpc-4332	4	4	.	.	PUNCT
dpc-4332	5	1	2024;14(4):e2024233	2024;14(4):e2024233	X
dpc-4332	5	2	.	.	X
dpc-4332	5	3	doi	doi	NOUN
dpc-4332	5	4	:	:	PUNCT
dpc-4332	5	5	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-4332	5	6	dpc.1404a233	dpc.1404a233	NUM
dpc-4332	5	7	accepted	accept	VERB
dpc-4332	5	8	:	:	PUNCT
dpc-4332	5	9	june	june	PROPN
dpc-4332	5	10	3	3	NUM
dpc-4332	5	11	,	,	PUNCT
dpc-4332	5	12	2024	2024	NUM
dpc-4332	5	13	;	;	PUNCT
dpc-4332	5	14	published	publish	VERB
dpc-4332	5	15	:	:	PUNCT
dpc-4332	6	1	october	october	PROPN
dpc-4332	6	2	2024	2024	NUM
dpc-4332	6	3	copyright	copyright	NOUN
dpc-4332	6	4	:	:	PUNCT
dpc-4332	6	5	©	©	PROPN
dpc-4332	6	6	2024	2024	NUM
dpc-4332	6	7	blanchet	blanchet	PROPN
dpc-4332	6	8	et	et	PROPN
dpc-4332	6	9	al	al	PROPN
dpc-4332	6	10	.	.	PUNCT
dpc-4332	7	1	this	this	PRON
dpc-4332	7	2	is	be	AUX
dpc-4332	7	3	an	an	DET
dpc-4332	7	4	open	open	ADJ
dpc-4332	7	5	-	-	PUNCT
dpc-4332	7	6	access	access	NOUN
dpc-4332	7	7	article	article	NOUN
dpc-4332	7	8	distributed	distribute	VERB
dpc-4332	7	9	under	under	ADP
dpc-4332	7	10	the	the	DET
dpc-4332	7	11	terms	term	NOUN
dpc-4332	7	12	of	of	ADP
dpc-4332	7	13	the	the	DET
dpc-4332	7	14	creative	creative	ADJ
dpc-4332	7	15	commons	common	NOUN
dpc-4332	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4332	7	17	license	license	NOUN
dpc-4332	7	18	(	(	PUNCT
dpc-4332	7	19	by	by	ADP
dpc-4332	7	20	-	-	PUNCT
dpc-4332	7	21	nc-4.0	nc-4.0	NOUN
dpc-4332	7	22	)	)	PUNCT
dpc-4332	7	23	,	,	PUNCT
dpc-4332	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4332	7	25	,	,	PUNCT
dpc-4332	7	26	which	which	PRON
dpc-4332	7	27	permits	permit	VERB
dpc-4332	7	28	unrestricted	unrestricted	ADJ
dpc-4332	7	29	noncommercial	noncommercial	ADJ
dpc-4332	7	30	use	use	NOUN
dpc-4332	7	31	,	,	PUNCT
dpc-4332	7	32	distribution	distribution	NOUN
dpc-4332	7	33	,	,	PUNCT
dpc-4332	7	34	and	and	CCONJ
dpc-4332	7	35	reproduction	reproduction	NOUN
dpc-4332	7	36	in	in	ADP
dpc-4332	7	37	any	any	DET
dpc-4332	7	38	medium	medium	NOUN
dpc-4332	7	39	,	,	PUNCT
dpc-4332	7	40	provided	provide	VERB
dpc-4332	7	41	the	the	DET
dpc-4332	7	42	original	original	ADJ
dpc-4332	7	43	authors	author	NOUN
dpc-4332	7	44	and	and	CCONJ
dpc-4332	7	45	source	source	NOUN
dpc-4332	7	46	are	be	AUX
dpc-4332	7	47	credited	credit	VERB
dpc-4332	7	48	.	.	PUNCT
dpc-4332	8	1	funding	funding	NOUN
dpc-4332	8	2	:	:	PUNCT
dpc-4332	8	3	none	none	NOUN
dpc-4332	8	4	.	.	PUNCT
dpc-4332	9	1	competing	compete	VERB
dpc-4332	9	2	interests	interest	NOUN
dpc-4332	9	3	:	:	PUNCT
dpc-4332	9	4	none	none	NOUN
dpc-4332	9	5	.	.	PUNCT
dpc-4332	10	1	authorship	authorship	NOUN
dpc-4332	10	2	:	:	PUNCT
dpc-4332	10	3	all	all	DET
dpc-4332	10	4	authors	author	NOUN
dpc-4332	10	5	have	have	AUX
dpc-4332	10	6	contributed	contribute	VERB
dpc-4332	10	7	significantly	significantly	ADV
dpc-4332	10	8	to	to	ADP
dpc-4332	10	9	this	this	DET
dpc-4332	10	10	publication	publication	NOUN
dpc-4332	10	11	.	.	PUNCT
dpc-4332	11	1	corresponding	correspond	VERB
dpc-4332	11	2	author	author	NOUN
dpc-4332	11	3	:	:	PUNCT
dpc-4332	11	4	françois	françois	PROPN
dpc-4332	11	5	-	-	PUNCT
dpc-4332	11	6	xavier	xavier	PROPN
dpc-4332	11	7	blanchet	blanchet	PROPN
dpc-4332	11	8	,	,	PUNCT
dpc-4332	11	9	department	department	PROPN
dpc-4332	11	10	of	of	ADP
dpc-4332	11	11	geriatric	geriatric	ADJ
dpc-4332	11	12	wound	wound	NOUN
dpc-4332	11	13	and	and	CCONJ
dpc-4332	11	14	healing	healing	NOUN
dpc-4332	11	15	,	,	PUNCT
dpc-4332	11	16	rothschild	rothschild	PROPN
dpc-4332	11	17	hospital	hospital	NOUN
dpc-4332	11	18	,	,	PUNCT
dpc-4332	11	19	aphp	aphp	ADJ
dpc-4332	11	20	,	,	PUNCT
dpc-4332	11	21	paris	paris	PROPN
dpc-4332	11	22	,	,	PUNCT
dpc-4332	11	23	france	france	PROPN
dpc-4332	11	24	.	.	PUNCT
dpc-4332	12	1	email	email	NOUN
dpc-4332	12	2	:	:	PUNCT
dpc-4332	12	3	francois-xavier.blanchet@aphp.fr	francois-xavier.blanchet@aphp.fr	PROPN
dpc-4332	12	4	introduction	introduction	NOUN
dpc-4332	12	5	ecthyma	ecthyma	NOUN
dpc-4332	12	6	gangrenosum	gangrenosum	NOUN
dpc-4332	12	7	(	(	PUNCT
dpc-4332	12	8	eg	eg	NOUN
dpc-4332	12	9	)	)	PUNCT
dpc-4332	12	10	is	be	AUX
dpc-4332	12	11	a	a	DET
dpc-4332	12	12	rare	rare	ADJ
dpc-4332	12	13	necrotizing	necrotizing	NOUN
dpc-4332	12	14	vasculitis	vasculitis	NOUN
dpc-4332	12	15	primarily	primarily	ADV
dpc-4332	12	16	caused	cause	VERB
dpc-4332	12	17	by	by	ADP
dpc-4332	12	18	pseudomonas	pseudomona	NOUN
dpc-4332	12	19	aeruginosa	aeruginosa	NOUN
dpc-4332	12	20	sepsis	sepsis	NOUN
dpc-4332	12	21	in	in	ADP
dpc-4332	12	22	immunocompromised	immunocompromise	VERB
dpc-4332	12	23	patients	patient	NOUN
dpc-4332	12	24	[	[	X
dpc-4332	12	25	1	1	NUM
dpc-4332	12	26	]	]	PUNCT
dpc-4332	12	27	.	.	PUNCT
dpc-4332	13	1	it	it	PRON
dpc-4332	13	2	is	be	AUX
dpc-4332	13	3	associated	associate	VERB
dpc-4332	13	4	with	with	ADP
dpc-4332	13	5	a	a	DET
dpc-4332	13	6	severe	severe	ADJ
dpc-4332	13	7	prognosis	prognosis	NOUN
dpc-4332	13	8	,	,	PUNCT
dpc-4332	13	9	with	with	ADP
dpc-4332	13	10	mortality	mortality	NOUN
dpc-4332	13	11	rates	rate	NOUN
dpc-4332	13	12	ranging	range	VERB
dpc-4332	13	13	from	from	ADP
dpc-4332	13	14	20	20	NUM
dpc-4332	13	15	%	%	NOUN
dpc-4332	13	16	to	to	PART
dpc-4332	13	17	77	77	NUM
dpc-4332	13	18	%	%	NOUN
dpc-4332	13	19	.	.	PUNCT
dpc-4332	14	1	we	we	PRON
dpc-4332	14	2	report	report	VERB
dpc-4332	14	3	a	a	DET
dpc-4332	14	4	case	case	NOUN
dpc-4332	14	5	of	of	ADP
dpc-4332	14	6	eg	eg	NOUN
dpc-4332	14	7	due	due	ADP
dpc-4332	14	8	to	to	ADP
dpc-4332	14	9	panton	panton	PROPN
dpc-4332	14	10	-	-	PUNCT
dpc-4332	14	11	valentine	valentine	PROPN
dpc-4332	14	12	leukocidin	leukocidin	VERB
dpc-4332	14	13	(	(	PUNCT
dpc-4332	14	14	pvl)-secreting	pvl)-secrete	VERB
dpc-4332	14	15	methicillin	methicillin	NOUN
dpc-4332	14	16	-	-	PUNCT
dpc-4332	14	17	sensitive	sensitive	ADJ
dpc-4332	14	18	staphylococcus	staphylococcus	NOUN
dpc-4332	14	19	aureus	aureus	NOUN
dpc-4332	14	20	(	(	PUNCT
dpc-4332	14	21	mssa	mssa	ADJ
dpc-4332	14	22	)	)	PUNCT
dpc-4332	14	23	in	in	ADP
dpc-4332	14	24	an	an	DET
dpc-4332	14	25	immunocompetent	immunocompetent	ADJ
dpc-4332	14	26	patient	patient	NOUN
dpc-4332	14	27	.	.	PUNCT
dpc-4332	15	1	case	case	NOUN
dpc-4332	15	2	presentation	presentation	NOUN
dpc-4332	15	3	a	a	DET
dpc-4332	15	4	77	77	NUM
dpc-4332	15	5	-	-	PUNCT
dpc-4332	15	6	year	year	NOUN
dpc-4332	15	7	-	-	PUNCT
dpc-4332	15	8	old	old	ADJ
dpc-4332	15	9	patient	patient	NOUN
dpc-4332	15	10	with	with	ADP
dpc-4332	15	11	no	no	DET
dpc-4332	15	12	history	history	NOUN
dpc-4332	15	13	presented	present	VERB
dpc-4332	15	14	with	with	ADP
dpc-4332	15	15	a	a	DET
dpc-4332	15	16	protuberant	protuberant	ADJ
dpc-4332	15	17	necrotic	necrotic	ADJ
dpc-4332	15	18	purulent	purulent	NOUN
dpc-4332	15	19	and	and	CCONJ
dpc-4332	15	20	very	very	ADV
dpc-4332	15	21	painful	painful	ADJ
dpc-4332	15	22	posterior	posterior	ADJ
dpc-4332	15	23	cervical	cervical	ADJ
dpc-4332	15	24	lesion	lesion	NOUN
dpc-4332	15	25	that	that	PRON
dpc-4332	15	26	had	have	AUX
dpc-4332	15	27	been	be	AUX
dpc-4332	15	28	evolving	evolve	VERB
dpc-4332	15	29	for	for	ADP
dpc-4332	15	30	six	six	NUM
dpc-4332	15	31	weeks	week	NOUN
dpc-4332	15	32	(	(	PUNCT
dpc-4332	15	33	figure	figure	NOUN
dpc-4332	15	34	1a	1a	NOUN
dpc-4332	15	35	)	)	PUNCT
dpc-4332	15	36	and	and	CCONJ
dpc-4332	15	37	with	with	ADP
dpc-4332	15	38	scalp	scalp	NOUN
dpc-4332	15	39	furunculosis	furunculosis	NOUN
dpc-4332	15	40	(	(	PUNCT
dpc-4332	15	41	figure	figure	NOUN
dpc-4332	15	42	1b	1b	NUM
dpc-4332	15	43	)	)	PUNCT
dpc-4332	15	44	.	.	PUNCT
dpc-4332	16	1	the	the	DET
dpc-4332	16	2	medical	medical	ADJ
dpc-4332	16	3	history	history	NOUN
dpc-4332	16	4	began	begin	VERB
dpc-4332	16	5	five	five	NUM
dpc-4332	16	6	months	month	NOUN
dpc-4332	16	7	earlier	early	ADV
dpc-4332	16	8	with	with	ADP
dpc-4332	16	9	a	a	DET
dpc-4332	16	10	furuncle	furuncle	NOUN
dpc-4332	16	11	on	on	ADP
dpc-4332	16	12	the	the	DET
dpc-4332	16	13	chest	chest	NOUN
dpc-4332	16	14	,	,	PUNCT
dpc-4332	16	15	followed	follow	VERB
dpc-4332	16	16	by	by	ADP
dpc-4332	16	17	a	a	DET
dpc-4332	16	18	furuncle	furuncle	NOUN
dpc-4332	16	19	in	in	ADP
dpc-4332	16	20	the	the	DET
dpc-4332	16	21	right	right	ADJ
dpc-4332	16	22	inguinal	inguinal	ADJ
dpc-4332	16	23	fold	fold	NOUN
dpc-4332	16	24	and	and	CCONJ
dpc-4332	16	25	in	in	ADP
dpc-4332	16	26	the	the	DET
dpc-4332	16	27	buttock	buttock	NOUN
dpc-4332	16	28	crease	crease	NOUN
dpc-4332	16	29	.	.	PUNCT
dpc-4332	17	1	then	then	ADV
dpc-4332	17	2	,	,	PUNCT
dpc-4332	17	3	following	follow	VERB
dpc-4332	17	4	a	a	DET
dpc-4332	17	5	post	post	ADJ
dpc-4332	17	6	-	-	ADJ
dpc-4332	17	7	traumatic	traumatic	ADJ
dpc-4332	17	8	wound	wound	NOUN
dpc-4332	17	9	of	of	ADP
dpc-4332	17	10	the	the	DET
dpc-4332	17	11	neck	neck	NOUN
dpc-4332	17	12	,	,	PUNCT
dpc-4332	17	13	the	the	DET
dpc-4332	17	14	lesion	lesion	NOUN
dpc-4332	17	15	appeared	appear	VERB
dpc-4332	17	16	with	with	ADP
dpc-4332	17	17	a	a	DET
dpc-4332	17	18	highly	highly	ADV
dpc-4332	17	19	inflammatory	inflammatory	ADJ
dpc-4332	17	20	periphery	periphery	NOUN
dpc-4332	17	21	extending	extend	VERB
dpc-4332	17	22	over	over	ADP
dpc-4332	17	23	the	the	DET
dpc-4332	17	24	entire	entire	ADJ
dpc-4332	17	25	root	root	NOUN
dpc-4332	17	26	of	of	ADP
dpc-4332	17	27	the	the	DET
dpc-4332	17	28	scalp	scalp	NOUN
dpc-4332	17	29	.	.	PUNCT
dpc-4332	18	1	despite	despite	SCONJ
dpc-4332	18	2	two	two	NUM
dpc-4332	18	3	courses	course	NOUN
dpc-4332	18	4	of	of	ADP
dpc-4332	18	5	antibiotics	antibiotic	NOUN
dpc-4332	18	6	(	(	PUNCT
dpc-4332	18	7	pristinamycin	pristinamycin	NOUN
dpc-4332	18	8	7	7	NUM
dpc-4332	18	9	days	day	NOUN
dpc-4332	18	10	,	,	PUNCT
dpc-4332	18	11	cloxacillin	cloxacillin	NOUN
dpc-4332	18	12	10	10	NUM
dpc-4332	18	13	days	day	NOUN
dpc-4332	18	14	)	)	PUNCT
dpc-4332	18	15	,	,	PUNCT
dpc-4332	18	16	the	the	DET
dpc-4332	18	17	patient	patient	NOUN
dpc-4332	18	18	’s	’s	PART
dpc-4332	18	19	condition	condition	NOUN
dpc-4332	18	20	rapidly	rapidly	ADV
dpc-4332	18	21	deteriorated	deteriorate	VERB
dpc-4332	18	22	.	.	PUNCT
dpc-4332	19	1	eg	eg	PROPN
dpc-4332	19	2	was	be	AUX
dpc-4332	19	3	suspected	suspect	VERB
dpc-4332	19	4	,	,	PUNCT
dpc-4332	19	5	and	and	CCONJ
dpc-4332	19	6	a	a	DET
dpc-4332	19	7	pus	pus	NOUN
dpc-4332	19	8	swab	swab	NOUN
dpc-4332	19	9	was	be	AUX
dpc-4332	19	10	taken	take	VERB
dpc-4332	19	11	.	.	PUNCT
dpc-4332	20	1	a	a	DET
dpc-4332	20	2	cervical	cervical	ADJ
dpc-4332	20	3	ct	ct	NOUN
dpc-4332	20	4	scan	scan	NOUN
dpc-4332	20	5	revealed	reveal	VERB
dpc-4332	20	6	extensive	extensive	ADJ
dpc-4332	20	7	infiltration	infiltration	NOUN
dpc-4332	20	8	of	of	ADP
dpc-4332	20	9	superficial	superficial	ADJ
dpc-4332	20	10	tissues	tissue	NOUN
dpc-4332	20	11	of	of	ADP
dpc-4332	20	12	the	the	DET
dpc-4332	20	13	neck	neck	NOUN
dpc-4332	20	14	with	with	ADP
dpc-4332	20	15	no	no	DET
dpc-4332	20	16	identifiable	identifiable	ADJ
dpc-4332	20	17	collection	collection	NOUN
dpc-4332	20	18	.	.	PUNCT
dpc-4332	21	1	drainage	drainage	NOUN
dpc-4332	21	2	with	with	ADP
dpc-4332	21	3	washing	washing	NOUN
dpc-4332	21	4	(	(	PUNCT
dpc-4332	21	5	figure	figure	NOUN
dpc-4332	21	6	2a	2a	NUM
dpc-4332	21	7	)	)	PUNCT
dpc-4332	21	8	and	and	CCONJ
dpc-4332	21	9	samples	sample	NOUN
dpc-4332	21	10	for	for	ADP
dpc-4332	21	11	bacteriological	bacteriological	ADJ
dpc-4332	21	12	,	,	PUNCT
dpc-4332	21	13	mycological	mycological	ADJ
dpc-4332	21	14	,	,	PUNCT
dpc-4332	21	15	mycobacterial	mycobacterial	ADJ
dpc-4332	21	16	,	,	PUNCT
dpc-4332	21	17	and	and	CCONJ
dpc-4332	21	18	histological	histological	ADJ
dpc-4332	21	19	testing	testing	NOUN
dpc-4332	21	20	were	be	AUX
dpc-4332	21	21	taken	take	VERB
dpc-4332	21	22	.	.	PUNCT
dpc-4332	22	1	the	the	DET
dpc-4332	22	2	pus	pus	PROPN
dpc-4332	22	3	swab	swab	NOUN
dpc-4332	22	4	was	be	AUX
dpc-4332	22	5	positive	positive	ADJ
dpc-4332	22	6	for	for	ADP
dpc-4332	22	7	mssa	mssa	ADJ
dpc-4332	22	8	,	,	PUNCT
dpc-4332	22	9	and	and	CCONJ
dpc-4332	22	10	in	in	ADP
dpc-4332	22	11	view	view	NOUN
dpc-4332	22	12	of	of	ADP
dpc-4332	22	13	this	this	DET
dpc-4332	22	14	atypical	atypical	ADJ
dpc-4332	22	15	clinical	clinical	ADJ
dpc-4332	22	16	presentation	presentation	NOUN
dpc-4332	22	17	,	,	PUNCT
dpc-4332	22	18	the	the	DET
dpc-4332	22	19	pvl	pvl	NOUN
dpc-4332	22	20	test	test	NOUN
dpc-4332	22	21	was	be	AUX
dpc-4332	22	22	performed	perform	VERB
dpc-4332	22	23	2	2	NUM
dpc-4332	22	24	research	research	NOUN
dpc-4332	22	25	letter	letter	NOUN
dpc-4332	22	26	|	|	ADV
dpc-4332	22	27	dermatol	dermatol	ADJ
dpc-4332	22	28	pract	pract	NOUN
dpc-4332	22	29	concept	concept	NOUN
dpc-4332	22	30	.	.	PUNCT
dpc-4332	23	1	2024;14(4):e2024233	2024;14(4):e2024233	NUM
dpc-4332	24	1	and	and	CCONJ
dpc-4332	24	2	came	come	VERB
dpc-4332	24	3	back	back	ADV
dpc-4332	24	4	positive	positive	ADJ
dpc-4332	24	5	.	.	PUNCT
dpc-4332	25	1	histological	histological	ADJ
dpc-4332	25	2	findings	finding	NOUN
dpc-4332	25	3	were	be	AUX
dpc-4332	25	4	inconclusive	inconclusive	ADJ
dpc-4332	25	5	.	.	PUNCT
dpc-4332	26	1	we	we	PRON
dpc-4332	26	2	concluded	conclude	VERB
dpc-4332	26	3	that	that	SCONJ
dpc-4332	26	4	the	the	DET
dpc-4332	26	5	patient	patient	NOUN
dpc-4332	26	6	had	have	VERB
dpc-4332	26	7	non	non	ADJ
dpc-4332	26	8	-	-	ADJ
dpc-4332	26	9	bacteremic	bacteremic	ADJ
dpc-4332	26	10	eg	eg	NOUN
dpc-4332	26	11	secondary	secondary	ADJ
dpc-4332	26	12	to	to	ADP
dpc-4332	26	13	pvl	pvl	NOUN
dpc-4332	26	14	-	-	PUNCT
dpc-4332	26	15	secreting	secrete	VERB
dpc-4332	26	16	mssa	mssa	NOUN
dpc-4332	26	17	.	.	PUNCT
dpc-4332	27	1	in	in	ADP
dpc-4332	27	2	view	view	NOUN
dpc-4332	27	3	of	of	ADP
dpc-4332	27	4	the	the	DET
dpc-4332	27	5	pvl	pvl	NOUN
dpc-4332	27	6	,	,	PUNCT
dpc-4332	27	7	treatment	treatment	NOUN
dpc-4332	27	8	with	with	ADP
dpc-4332	27	9	clindamycin	clindamycin	NOUN
dpc-4332	28	1	600	600	NUM
dpc-4332	28	2	mg	mg	NUM
dpc-4332	28	3	4	4	NUM
dpc-4332	28	4	times	time	NOUN
dpc-4332	28	5	a	a	DET
dpc-4332	28	6	day	day	NOUN
dpc-4332	28	7	was	be	AUX
dpc-4332	28	8	initiated	initiate	VERB
dpc-4332	28	9	for	for	ADP
dpc-4332	28	10	10	10	NUM
dpc-4332	28	11	days	day	NOUN
dpc-4332	28	12	.	.	PUNCT
dpc-4332	29	1	we	we	PRON
dpc-4332	29	2	also	also	ADV
dpc-4332	29	3	implemented	implement	VERB
dpc-4332	29	4	a	a	DET
dpc-4332	29	5	s.	s.	PROPN
dpc-4332	29	6	aureus	aureus	PROPN
dpc-4332	29	7	topical	topical	ADJ
dpc-4332	29	8	decolonization	decolonization	NOUN
dpc-4332	29	9	protocol	protocol	NOUN
dpc-4332	29	10	.	.	PUNCT
dpc-4332	30	1	after	after	ADP
dpc-4332	30	2	surgical	surgical	ADJ
dpc-4332	30	3	debridement	debridement	NOUN
dpc-4332	30	4	,	,	PUNCT
dpc-4332	30	5	management	management	NOUN
dpc-4332	30	6	consisted	consist	VERB
dpc-4332	30	7	of	of	ADP
dpc-4332	30	8	negative	negative	ADJ
dpc-4332	30	9	pressure	pressure	NOUN
dpc-4332	30	10	therapy	therapy	NOUN
dpc-4332	30	11	(	(	PUNCT
dpc-4332	30	12	figure	figure	NOUN
dpc-4332	30	13	2b	2b	NOUN
dpc-4332	30	14	)	)	PUNCT
dpc-4332	30	15	.	.	PUNCT
dpc-4332	31	1	this	this	DET
dpc-4332	31	2	atypical	atypical	ADJ
dpc-4332	31	3	clinical	clinical	ADJ
dpc-4332	31	4	presentation	presentation	NOUN
dpc-4332	31	5	led	lead	VERB
dpc-4332	31	6	us	we	PRON
dpc-4332	31	7	to	to	PART
dpc-4332	31	8	conduct	conduct	VERB
dpc-4332	31	9	a	a	DET
dpc-4332	31	10	large	large	ADJ
dpc-4332	31	11	immunologic	immunologic	ADJ
dpc-4332	31	12	analysis	analysis	NOUN
dpc-4332	31	13	,	,	PUNCT
dpc-4332	31	14	including	include	VERB
dpc-4332	31	15	immunoglobulin	immunoglobulin	NOUN
dpc-4332	31	16	subtypes	subtype	NOUN
dpc-4332	31	17	and	and	CCONJ
dpc-4332	31	18	complete	complete	ADJ
dpc-4332	31	19	immunophenotyping	immunophenotyping	NOUN
dpc-4332	31	20	of	of	ADP
dpc-4332	31	21	circulating	circulate	VERB
dpc-4332	31	22	lymphocytes	lymphocyte	NOUN
dpc-4332	31	23	,	,	PUNCT
dpc-4332	31	24	but	but	CCONJ
dpc-4332	31	25	no	no	DET
dpc-4332	31	26	immune	immune	ADJ
dpc-4332	31	27	deficiency	deficiency	NOUN
dpc-4332	31	28	was	be	AUX
dpc-4332	31	29	identified	identify	VERB
dpc-4332	31	30	.	.	PUNCT
dpc-4332	32	1	we	we	PRON
dpc-4332	32	2	also	also	ADV
dpc-4332	32	3	suspected	suspect	VERB
dpc-4332	32	4	the	the	DET
dpc-4332	32	5	existence	existence	NOUN
dpc-4332	32	6	of	of	ADP
dpc-4332	32	7	an	an	DET
dpc-4332	32	8	underlying	underlying	ADJ
dpc-4332	32	9	skin	skin	NOUN
dpc-4332	32	10	condition	condition	NOUN
dpc-4332	32	11	that	that	PRON
dpc-4332	32	12	could	could	AUX
dpc-4332	32	13	have	have	AUX
dpc-4332	32	14	served	serve	VERB
dpc-4332	32	15	as	as	ADP
dpc-4332	32	16	a	a	DET
dpc-4332	32	17	gateway	gateway	NOUN
dpc-4332	32	18	,	,	PUNCT
dpc-4332	32	19	such	such	ADJ
dpc-4332	32	20	as	as	ADP
dpc-4332	32	21	quinquaud	quinquaud	NOUN
dpc-4332	32	22	’s	’s	PART
dpc-4332	32	23	disease	disease	NOUN
dpc-4332	32	24	,	,	PUNCT
dpc-4332	32	25	dissecting	dissect	VERB
dpc-4332	32	26	cellulitis	cellulitis	NOUN
dpc-4332	32	27	,	,	PUNCT
dpc-4332	32	28	or	or	CCONJ
dpc-4332	32	29	erosive	erosive	VERB
dpc-4332	32	30	pustular	pustular	ADJ
dpc-4332	32	31	dermatosis	dermatosis	NOUN
dpc-4332	32	32	of	of	ADP
dpc-4332	32	33	the	the	DET
dpc-4332	32	34	scalp	scalp	NOUN
dpc-4332	32	35	.	.	PUNCT
dpc-4332	33	1	however	however	ADV
dpc-4332	33	2	,	,	PUNCT
dpc-4332	33	3	investigations	investigation	NOUN
dpc-4332	33	4	of	of	ADP
dpc-4332	33	5	such	such	ADJ
dpc-4332	33	6	condition	condition	NOUN
dpc-4332	33	7	have	have	AUX
dpc-4332	33	8	not	not	PART
dpc-4332	33	9	been	be	AUX
dpc-4332	33	10	carried	carry	VERB
dpc-4332	33	11	out	out	ADP
dpc-4332	33	12	yet	yet	ADV
dpc-4332	33	13	because	because	SCONJ
dpc-4332	33	14	the	the	DET
dpc-4332	33	15	lesions	lesion	NOUN
dpc-4332	33	16	regressed	regress	VERB
dpc-4332	33	17	after	after	ADP
dpc-4332	33	18	treatment	treatment	NOUN
dpc-4332	33	19	.	.	PUNCT
dpc-4332	34	1	discussion	discussion	NOUN
dpc-4332	34	2	only	only	ADV
dpc-4332	34	3	few	few	ADJ
dpc-4332	34	4	cases	case	NOUN
dpc-4332	34	5	of	of	ADP
dpc-4332	34	6	eg	eg	NOUN
dpc-4332	34	7	have	have	AUX
dpc-4332	34	8	been	be	AUX
dpc-4332	34	9	observed	observe	VERB
dpc-4332	34	10	in	in	ADP
dpc-4332	34	11	immunocompetent	immunocompetent	ADJ
dpc-4332	34	12	patients	patient	NOUN
dpc-4332	34	13	[	[	X
dpc-4332	34	14	2	2	NUM
dpc-4332	34	15	]	]	PUNCT
dpc-4332	34	16	.	.	PUNCT
dpc-4332	35	1	cases	case	NOUN
dpc-4332	35	2	of	of	ADP
dpc-4332	35	3	eg	eg	NOUN
dpc-4332	35	4	secondary	secondary	ADJ
dpc-4332	35	5	to	to	ADP
dpc-4332	35	6	s.	s.	PROPN
dpc-4332	35	7	aureus	aureus	PROPN
dpc-4332	35	8	(	(	PUNCT
dpc-4332	35	9	methicillin	methicillin	NOUN
dpc-4332	35	10	-	-	PUNCT
dpc-4332	35	11	resistant	resistant	ADJ
dpc-4332	35	12	or	or	CCONJ
dpc-4332	35	13	not	not	PART
dpc-4332	35	14	)	)	PUNCT
dpc-4332	35	15	have	have	AUX
dpc-4332	35	16	been	be	AUX
dpc-4332	35	17	reported	report	VERB
dpc-4332	35	18	,	,	PUNCT
dpc-4332	35	19	but	but	CCONJ
dpc-4332	35	20	only	only	ADV
dpc-4332	35	21	in	in	ADP
dpc-4332	35	22	immunocompromised	immunocompromise	VERB
dpc-4332	35	23	patients	patient	NOUN
dpc-4332	35	24	,	,	PUNCT
dpc-4332	35	25	with	with	SCONJ
dpc-4332	35	26	pvl	pvl	PROPN
dpc-4332	35	27	screened	screen	VERB
dpc-4332	35	28	only	only	ADV
dpc-4332	35	29	once	once	ADV
dpc-4332	35	30	,	,	PUNCT
dpc-4332	35	31	and	and	CCONJ
dpc-4332	35	32	tested	test	VERB
dpc-4332	35	33	negative	negative	ADJ
dpc-4332	35	34	[	[	X
dpc-4332	35	35	3,4	3,4	NUM
dpc-4332	35	36	]	]	PUNCT
dpc-4332	35	37	.	.	PUNCT
dpc-4332	36	1	in	in	ADP
dpc-4332	36	2	france	france	PROPN
dpc-4332	36	3	,	,	PUNCT
dpc-4332	36	4	the	the	DET
dpc-4332	36	5	prevalence	prevalence	NOUN
dpc-4332	36	6	of	of	ADP
dpc-4332	36	7	mssa	mssa	ADJ
dpc-4332	36	8	positive	positive	ADJ
dpc-4332	36	9	for	for	ADP
dpc-4332	36	10	pvl	pvl	PROPN
dpc-4332	36	11	is	be	AUX
dpc-4332	36	12	approximately	approximately	ADV
dpc-4332	36	13	5	5	NUM
dpc-4332	36	14	%	%	NOUN
dpc-4332	36	15	,	,	PUNCT
dpc-4332	36	16	and	and	CCONJ
dpc-4332	36	17	pvl	pvl	NOUN
dpc-4332	36	18	diagnosis	diagnosis	NOUN
dpc-4332	36	19	is	be	AUX
dpc-4332	36	20	not	not	PART
dpc-4332	36	21	automatically	automatically	ADV
dpc-4332	36	22	performed	perform	VERB
dpc-4332	36	23	when	when	SCONJ
dpc-4332	36	24	s.	s.	PROPN
dpc-4332	36	25	aureus	aureus	PROPN
dpc-4332	36	26	is	be	AUX
dpc-4332	36	27	detected	detect	VERB
dpc-4332	36	28	in	in	ADP
dpc-4332	36	29	microbiology	microbiology	NOUN
dpc-4332	36	30	.	.	PUNCT
dpc-4332	37	1	furunculosis	furunculosis	NOUN
dpc-4332	37	2	,	,	PUNCT
dpc-4332	37	3	multiple	multiple	ADJ
dpc-4332	37	4	lesions	lesion	NOUN
dpc-4332	37	5	,	,	PUNCT
dpc-4332	37	6	or	or	CCONJ
dpc-4332	37	7	deep	deep	ADV
dpc-4332	37	8	-	-	PUNCT
dpc-4332	37	9	seated	seat	VERB
dpc-4332	37	10	abscess	abscess	NOUN
dpc-4332	37	11	can	can	AUX
dpc-4332	37	12	be	be	AUX
dpc-4332	37	13	found	find	VERB
dpc-4332	37	14	in	in	ADP
dpc-4332	37	15	pvl	pvl	NOUN
dpc-4332	37	16	infections	infection	NOUN
dpc-4332	37	17	,	,	PUNCT
dpc-4332	37	18	and	and	CCONJ
dpc-4332	37	19	their	their	PRON
dpc-4332	37	20	presence	presence	NOUN
dpc-4332	37	21	should	should	AUX
dpc-4332	37	22	lead	lead	VERB
dpc-4332	37	23	to	to	ADP
dpc-4332	37	24	pvl	pvl	PROPN
dpc-4332	37	25	testing	testing	NOUN
dpc-4332	37	26	[	[	X
dpc-4332	37	27	5	5	NUM
dpc-4332	37	28	]	]	PUNCT
dpc-4332	37	29	.	.	PUNCT
dpc-4332	38	1	the	the	DET
dpc-4332	38	2	occurrence	occurrence	NOUN
dpc-4332	38	3	of	of	ADP
dpc-4332	38	4	eg	eg	PROPN
dpc-4332	38	5	secondary	secondary	ADJ
dpc-4332	38	6	to	to	ADP
dpc-4332	38	7	s.	s.	PROPN
dpc-4332	38	8	aureus	aureus	PROPN
dpc-4332	38	9	in	in	ADP
dpc-4332	38	10	this	this	DET
dpc-4332	38	11	immunocompetent	immunocompetent	ADJ
dpc-4332	38	12	patient	patient	NOUN
dpc-4332	38	13	might	might	AUX
dpc-4332	38	14	be	be	AUX
dpc-4332	38	15	a	a	DET
dpc-4332	38	16	consequence	consequence	NOUN
dpc-4332	38	17	of	of	ADP
dpc-4332	38	18	pvl	pvl	PROPN
dpc-4332	38	19	’s	’s	PART
dpc-4332	38	20	pathogenicity	pathogenicity	NOUN
dpc-4332	38	21	,	,	PUNCT
dpc-4332	38	22	involving	involve	VERB
dpc-4332	38	23	bacterial	bacterial	ADJ
dpc-4332	38	24	invasion	invasion	NOUN
dpc-4332	38	25	of	of	ADP
dpc-4332	38	26	dermal	dermal	ADJ
dpc-4332	38	27	vessel	vessel	NOUN
dpc-4332	38	28	walls	wall	NOUN
dpc-4332	38	29	and	and	CCONJ
dpc-4332	38	30	tissue	tissue	NOUN
dpc-4332	38	31	necrosis	necrosis	NOUN
dpc-4332	38	32	.	.	PUNCT
dpc-4332	39	1	regarding	regard	VERB
dpc-4332	39	2	antibiotic	antibiotic	ADJ
dpc-4332	39	3	therapy	therapy	NOUN
dpc-4332	39	4	,	,	PUNCT
dpc-4332	39	5	oxacillin	oxacillin	NOUN
dpc-4332	39	6	and	and	CCONJ
dpc-4332	39	7	other	other	ADJ
dpc-4332	39	8	β	β	NOUN
dpc-4332	39	9	-	-	PUNCT
dpc-4332	39	10	lactams	lactam	NOUN
dpc-4332	39	11	increase	increase	VERB
dpc-4332	39	12	pvl	pvl	NOUN
dpc-4332	39	13	production	production	NOUN
dpc-4332	39	14	,	,	PUNCT
dpc-4332	39	15	whereas	whereas	SCONJ
dpc-4332	39	16	figure	figure	NOUN
dpc-4332	39	17	1	1	NUM
dpc-4332	39	18	.	.	PUNCT
dpc-4332	40	1	(	(	PUNCT
dpc-4332	40	2	a	a	X
dpc-4332	40	3	)	)	PUNCT
dpc-4332	40	4	clinical	clinical	ADJ
dpc-4332	40	5	ecthyma	ecthyma	NOUN
dpc-4332	40	6	gangrenosum	gangrenosum	NOUN
dpc-4332	40	7	.	.	PUNCT
dpc-4332	41	1	(	(	PUNCT
dpc-4332	41	2	b	b	X
dpc-4332	41	3	)	)	PUNCT
dpc-4332	41	4	scalp	scalp	NOUN
dpc-4332	41	5	furunculosis	furunculosis	NOUN
dpc-4332	41	6	.	.	PUNCT
dpc-4332	42	1	figure	figure	NOUN
dpc-4332	42	2	2	2	NUM
dpc-4332	42	3	.	.	PUNCT
dpc-4332	43	1	(	(	PUNCT
dpc-4332	43	2	a	a	X
dpc-4332	43	3	)	)	PUNCT
dpc-4332	43	4	one	one	NUM
dpc-4332	43	5	day	day	NOUN
dpc-4332	43	6	after	after	ADP
dpc-4332	43	7	surgery	surgery	NOUN
dpc-4332	43	8	.	.	PUNCT
dpc-4332	44	1	note	note	VERB
dpc-4332	44	2	the	the	DET
dpc-4332	44	3	persistence	persistence	NOUN
dpc-4332	44	4	of	of	ADP
dpc-4332	44	5	scalp	scalp	NOUN
dpc-4332	44	6	furunculosis	furunculosis	NOUN
dpc-4332	44	7	.	.	PUNCT
dpc-4332	45	1	(	(	PUNCT
dpc-4332	45	2	b	b	X
dpc-4332	45	3	)	)	PUNCT
dpc-4332	45	4	six	six	NUM
dpc-4332	45	5	weeks	week	NOUN
dpc-4332	45	6	after	after	ADP
dpc-4332	45	7	surgery	surgery	NOUN
dpc-4332	45	8	(	(	PUNCT
dpc-4332	45	9	and	and	CCONJ
dpc-4332	45	10	12	12	NUM
dpc-4332	45	11	days	day	NOUN
dpc-4332	45	12	after	after	ADP
dpc-4332	45	13	negative	negative	ADJ
dpc-4332	45	14	pressure	pressure	NOUN
dpc-4332	45	15	therapy	therapy	NOUN
dpc-4332	45	16	)	)	PUNCT
dpc-4332	45	17	.	.	PUNCT
dpc-4332	46	1	research	research	NOUN
dpc-4332	46	2	letter	letter	NOUN
dpc-4332	46	3	|	|	ADV
dpc-4332	46	4	dermatol	dermatol	ADJ
dpc-4332	46	5	pract	pract	NOUN
dpc-4332	46	6	concept	concept	NOUN
dpc-4332	46	7	.	.	PUNCT
dpc-4332	47	1	2024;14(4):e2024233	2024;14(4):e2024233	NUM
dpc-4332	47	2	3	3	NUM
dpc-4332	47	3	clindamycin	clindamycin	NOUN
dpc-4332	47	4	or	or	CCONJ
dpc-4332	47	5	linezolid	linezolid	NOUN
dpc-4332	47	6	are	be	AUX
dpc-4332	47	7	usually	usually	ADV
dpc-4332	47	8	effective	effective	ADJ
dpc-4332	47	9	against	against	ADP
dpc-4332	47	10	pvl	pvl	PROPN
dpc-4332	47	11	due	due	ADP
dpc-4332	47	12	to	to	ADP
dpc-4332	47	13	their	their	PRON
dpc-4332	47	14	inhibitory	inhibitory	ADJ
dpc-4332	47	15	action	action	NOUN
dpc-4332	47	16	on	on	ADP
dpc-4332	47	17	protein	protein	NOUN
dpc-4332	47	18	synthesis	synthesis	NOUN
dpc-4332	47	19	[	[	X
dpc-4332	47	20	6	6	NUM
dpc-4332	47	21	]	]	PUNCT
dpc-4332	47	22	.	.	PUNCT
dpc-4332	48	1	we	we	PRON
dpc-4332	48	2	report	report	VERB
dpc-4332	48	3	an	an	DET
dpc-4332	48	4	atypical	atypical	ADJ
dpc-4332	48	5	case	case	NOUN
dpc-4332	48	6	of	of	ADP
dpc-4332	48	7	eg	eg	PROPN
dpc-4332	48	8	secondary	secondary	ADJ
dpc-4332	48	9	to	to	ADP
dpc-4332	48	10	pvl	pvl	PROPN
dpc-4332	48	11	secreting	secrete	VERB
dpc-4332	48	12	mssa	mssa	NOUN
dpc-4332	48	13	in	in	ADP
dpc-4332	48	14	an	an	DET
dpc-4332	48	15	immunocompetent	immunocompetent	ADJ
dpc-4332	48	16	patient	patient	NOUN
dpc-4332	48	17	.	.	PUNCT
dpc-4332	49	1	in	in	ADP
dpc-4332	49	2	cases	case	NOUN
dpc-4332	49	3	where	where	SCONJ
dpc-4332	49	4	patients	patient	NOUN
dpc-4332	49	5	exhibit	exhibit	VERB
dpc-4332	49	6	atypical	atypical	ADJ
dpc-4332	49	7	manifestations	manifestation	NOUN
dpc-4332	49	8	of	of	ADP
dpc-4332	49	9	eg	eg	NOUN
dpc-4332	49	10	,	,	PUNCT
dpc-4332	49	11	it	it	PRON
dpc-4332	49	12	is	be	AUX
dpc-4332	49	13	crucial	crucial	ADJ
dpc-4332	49	14	to	to	PART
dpc-4332	49	15	conduct	conduct	VERB
dpc-4332	49	16	pvl	pvl	NOUN
dpc-4332	49	17	testing	testing	NOUN
dpc-4332	49	18	to	to	PART
dpc-4332	49	19	determine	determine	VERB
dpc-4332	49	20	the	the	DET
dpc-4332	49	21	appropriate	appropriate	ADJ
dpc-4332	49	22	antibiotic	antibiotic	ADJ
dpc-4332	49	23	therapy	therapy	NOUN
dpc-4332	49	24	.	.	PUNCT
dpc-4332	50	1	references	reference	NOUN
dpc-4332	50	2	1	1	NUM
dpc-4332	50	3	.	.	PUNCT
dpc-4332	50	4	greene	greene	PROPN
dpc-4332	50	5	sl	sl	PROPN
dpc-4332	50	6	,	,	PUNCT
dpc-4332	50	7	daniel	daniel	PROPN
dpc-4332	50	8	su	su	PROPN
dpc-4332	50	9	wp	wp	PROPN
dpc-4332	50	10	,	,	PUNCT
dpc-4332	50	11	muller	muller	PROPN
dpc-4332	50	12	sa	sa	PROPN
dpc-4332	50	13	.	.	PROPN
dpc-4332	50	14	ecthyma	ecthyma	PROPN
dpc-4332	50	15	gangrenosum	gangrenosum	NOUN
dpc-4332	50	16	:	:	PUNCT
dpc-4332	50	17	report	report	NOUN
dpc-4332	50	18	of	of	ADP
dpc-4332	50	19	clinical	clinical	ADJ
dpc-4332	50	20	,	,	PUNCT
dpc-4332	50	21	histopathologic	histopathologic	NOUN
dpc-4332	50	22	,	,	PUNCT
dpc-4332	50	23	and	and	CCONJ
dpc-4332	50	24	bacteriologic	bacteriologic	ADJ
dpc-4332	50	25	aspects	aspect	NOUN
dpc-4332	50	26	of	of	ADP
dpc-4332	50	27	eight	eight	NUM
dpc-4332	50	28	cases	case	NOUN
dpc-4332	50	29	.	.	PUNCT
dpc-4332	51	1	j	j	PROPN
dpc-4332	51	2	am	be	AUX
dpc-4332	51	3	acad	acad	ADJ
dpc-4332	51	4	dermatol	dermatol	NOUN
dpc-4332	51	5	.	.	PUNCT
dpc-4332	52	1	1984;11(5):781	1984;11(5):781	NUM
dpc-4332	52	2	-	-	SYM
dpc-4332	52	3	787	787	NUM
dpc-4332	52	4	.	.	PUNCT
dpc-4332	52	5	doi:10.1016	doi:10.1016	PROPN
dpc-4332	52	6	/	/	SYM
dpc-4332	52	7	s0190	s0190	VERB
dpc-4332	52	8	-	-	PUNCT
dpc-4332	52	9	9622(84)80453	9622(84)80453	NUM
dpc-4332	52	10	-	-	SYM
dpc-4332	52	11	3	3	NUM
dpc-4332	52	12	2	2	NUM
dpc-4332	52	13	.	.	PUNCT
dpc-4332	52	14	gençer	gençer	PROPN
dpc-4332	52	15	s	s	PROPN
dpc-4332	52	16	,	,	PUNCT
dpc-4332	52	17	özer	özer	NOUN
dpc-4332	52	18	s	s	PROPN
dpc-4332	52	19	,	,	PUNCT
dpc-4332	52	20	ege	ege	PROPN
dpc-4332	52	21	gül	gül	PROPN
dpc-4332	52	22	a	a	PRON
dpc-4332	52	23	,	,	PUNCT
dpc-4332	52	24	doğan	doğan	PROPN
dpc-4332	52	25	m	m	PROPN
dpc-4332	52	26	,	,	PUNCT
dpc-4332	52	27	ak	ak	PROPN
dpc-4332	52	28	ö.	ö.	PROPN
dpc-4332	52	29	ecthyma	ecthyma	PROPN
dpc-4332	52	30	gangrenosum	gangrenosum	NOUN
dpc-4332	52	31	without	without	ADP
dpc-4332	52	32	bacteremia	bacteremia	NOUN
dpc-4332	52	33	in	in	ADP
dpc-4332	52	34	a	a	DET
dpc-4332	52	35	previously	previously	ADV
dpc-4332	52	36	healthy	healthy	ADJ
dpc-4332	52	37	man	man	NOUN
dpc-4332	52	38	:	:	PUNCT
dpc-4332	52	39	a	a	DET
dpc-4332	52	40	case	case	NOUN
dpc-4332	52	41	report	report	NOUN
dpc-4332	52	42	.	.	PUNCT
dpc-4332	53	1	j	j	PROPN
dpc-4332	53	2	med	med	PROPN
dpc-4332	53	3	case	case	NOUN
dpc-4332	53	4	reports	report	VERB
dpc-4332	53	5	.	.	PUNCT
dpc-4332	54	1	2008;2(1):14	2008;2(1):14	NUM
dpc-4332	54	2	.	.	PUNCT
dpc-4332	55	1	doi:10.1186/1752	doi:10.1186/1752	ADJ
dpc-4332	55	2	-	-	SYM
dpc-4332	55	3	1947	1947	NUM
dpc-4332	55	4	-2	-2	NOUN
dpc-4332	55	5	-	-	SYM
dpc-4332	55	6	14	14	NUM
dpc-4332	55	7	3	3	NUM
dpc-4332	55	8	.	.	PUNCT
dpc-4332	55	9	ungprasert	ungprasert	PROPN
dpc-4332	55	10	p	p	NOUN
dpc-4332	55	11	,	,	PUNCT
dpc-4332	55	12	permpalung	permpalung	PROPN
dpc-4332	55	13	n	n	CCONJ
dpc-4332	55	14	,	,	PUNCT
dpc-4332	55	15	kue	kue	PROPN
dpc-4332	55	16	-	-	PUNCT
dpc-4332	55	17	a	a	NOUN
dpc-4332	55	18	-	-	PUNCT
dpc-4332	55	19	pai	pai	NOUN
dpc-4332	55	20	p	p	NOUN
dpc-4332	55	21	,	,	PUNCT
dpc-4332	55	22	ammannagari	ammannagari	ADJ
dpc-4332	55	23	n	n	CCONJ
dpc-4332	55	24	,	,	PUNCT
dpc-4332	55	25	chongnarungsin	chongnarungsin	PROPN
dpc-4332	55	26	d.	d.	PROPN
dpc-4332	55	27	a	a	DET
dpc-4332	55	28	rare	rare	ADJ
dpc-4332	55	29	case	case	NOUN
dpc-4332	55	30	of	of	ADP
dpc-4332	55	31	ecthyma	ecthyma	NOUN
dpc-4332	55	32	gangrenosum	gangrenosum	NOUN
dpc-4332	55	33	associated	associate	VERB
dpc-4332	55	34	with	with	ADP
dpc-4332	55	35	methicillin	methicillin	NOUN
dpc-4332	55	36	-	-	PUNCT
dpc-4332	55	37	resistant	resistant	ADJ
dpc-4332	55	38	staphylococcus	staphylococcus	NOUN
dpc-4332	55	39	aureus	aureus	NOUN
dpc-4332	55	40	infection	infection	NOUN
dpc-4332	55	41	.	.	PUNCT
dpc-4332	56	1	j	j	PROPN
dpc-4332	56	2	infect	infect	PROPN
dpc-4332	56	3	chemother	chemother	PROPN
dpc-4332	56	4	.	.	PUNCT
dpc-4332	57	1	2013;19(4):761	2013;19(4):761	NUM
dpc-4332	57	2	-	-	SYM
dpc-4332	57	3	763	763	NUM
dpc-4332	57	4	.	.	PUNCT
dpc-4332	58	1	doi:10.1007	doi:10.1007	VERB
dpc-4332	58	2	/	/	SYM
dpc-4332	59	1	s10156	s10156	PROPN
dpc-4332	59	2	-012	-012	PROPN
dpc-4332	59	3	-	-	PUNCT
dpc-4332	59	4	0498	0498	NUM
dpc-4332	59	5	-	-	SYM
dpc-4332	59	6	0	0	NUM
dpc-4332	59	7	4	4	NUM
dpc-4332	59	8	.	.	PUNCT
dpc-4332	59	9	buffière	buffière	NOUN
dpc-4332	59	10	-	-	PUNCT
dpc-4332	59	11	morgado	morgado	PROPN
dpc-4332	59	12	a	a	PRON
dpc-4332	59	13	,	,	PUNCT
dpc-4332	59	14	demongeot	demongeot	NOUN
dpc-4332	59	15	c	c	NOUN
dpc-4332	59	16	,	,	PUNCT
dpc-4332	59	17	battistella	battistella	NOUN
dpc-4332	59	18	m	m	PROPN
dpc-4332	59	19	,	,	PUNCT
dpc-4332	59	20	et	et	PROPN
dpc-4332	59	21	al	al	PROPN
dpc-4332	59	22	.	.	PROPN
dpc-4332	59	23	ecthyma	ecthyma	PROPN
dpc-4332	59	24	gangréneux	gangréneux	PROPN
dpc-4332	59	25	dû	dû	PROPN
dpc-4332	59	26	à	à	X
dpc-4332	59	27	une	une	PROPN
dpc-4332	59	28	souche	souche	PROPN
dpc-4332	59	29	de	de	PROPN
dpc-4332	59	30	staphylococcus	staphylococcus	PROPN
dpc-4332	59	31	aureus	aureus	PROPN
dpc-4332	59	32	sensible	sensible	ADJ
dpc-4332	59	33	à	à	X
dpc-4332	59	34	la	la	X
dpc-4332	59	35	méthicilline	méthicilline	PROPN
dpc-4332	59	36	et	et	VERB
dpc-4332	59	37	non	non	ADJ
dpc-4332	59	38	sécrétrice	sécrétrice	PROPN
dpc-4332	59	39	de	de	X
dpc-4332	59	40	toxine	toxine	X
dpc-4332	59	41	de	de	PROPN
dpc-4332	59	42	panton	panton	PROPN
dpc-4332	59	43	valentine	valentine	PROPN
dpc-4332	59	44	.	.	PUNCT
dpc-4332	60	1	ann	ann	PROPN
dpc-4332	60	2	dermatol	dermatol	PROPN
dpc-4332	60	3	vénéréologie	vénéréologie	PROPN
dpc-4332	60	4	.	.	PUNCT
dpc-4332	61	1	2015;142(4):262	2015;142(4):262	PUNCT
dpc-4332	61	2	-	-	PUNCT
dpc-4332	61	3	265	265	NUM
dpc-4332	61	4	.	.	PUNCT
dpc-4332	62	1	doi:10.1016	doi:10.1016	PROPN
dpc-4332	62	2	/	/	SYM
dpc-4332	63	1	j.annder.2014.04.224	j.annder.2014.04.224	PROPN
dpc-4332	63	2	5	5	NUM
dpc-4332	63	3	.	.	PUNCT
dpc-4332	64	1	saeed	saeed	PROPN
dpc-4332	64	2	k	k	PROPN
dpc-4332	64	3	,	,	PUNCT
dpc-4332	64	4	gould	gould	PROPN
dpc-4332	65	1	i	i	PROPN
dpc-4332	65	2	,	,	PUNCT
dpc-4332	65	3	esposito	esposito	PROPN
dpc-4332	65	4	s	s	PROPN
dpc-4332	65	5	,	,	PUNCT
dpc-4332	65	6	et	et	PROPN
dpc-4332	65	7	al	al	PROPN
dpc-4332	65	8	.	.	PUNCT
dpc-4332	65	9	panton	panton	PROPN
dpc-4332	65	10	–	–	PUNCT
dpc-4332	65	11	valentine	valentine	NOUN
dpc-4332	65	12	leukocidin	leukocidin	ADJ
dpc-4332	65	13	-	-	PUNCT
dpc-4332	65	14	positive	positive	ADJ
dpc-4332	65	15	staphylococcus	staphylococcus	NOUN
dpc-4332	65	16	aureus	aureus	NOUN
dpc-4332	65	17	:	:	PUNCT
dpc-4332	65	18	a	a	DET
dpc-4332	65	19	position	position	NOUN
dpc-4332	65	20	statement	statement	NOUN
dpc-4332	65	21	from	from	ADP
dpc-4332	65	22	the	the	DET
dpc-4332	65	23	international	international	ADJ
dpc-4332	65	24	society	society	NOUN
dpc-4332	65	25	of	of	ADP
dpc-4332	65	26	chemotherapy	chemotherapy	NOUN
dpc-4332	65	27	.	.	PUNCT
dpc-4332	66	1	int	int	PROPN
dpc-4332	66	2	j	j	PROPN
dpc-4332	66	3	antimicrob	antimicrob	PROPN
dpc-4332	66	4	agents	agent	NOUN
dpc-4332	66	5	.	.	PUNCT
dpc-4332	67	1	2018;51(1):16	2018;51(1):16	NOUN
dpc-4332	67	2	-	-	SYM
dpc-4332	67	3	25	25	NUM
dpc-4332	67	4	.	.	PUNCT
dpc-4332	68	1	doi:10.1016	doi:10.1016	PROPN
dpc-4332	68	2	/	/	SYM
dpc-4332	68	3	j.ijantimicag.2017	j.ijantimicag.2017	PROPN
dpc-4332	68	4	.11.002	.11.002	PUNCT
dpc-4332	69	1	6	6	NUM
dpc-4332	69	2	.	.	PUNCT
dpc-4332	70	1	dumitrescu	dumitrescu	PROPN
dpc-4332	70	2	o	o	NOUN
dpc-4332	70	3	,	,	PUNCT
dpc-4332	70	4	boisset	boisset	NOUN
dpc-4332	70	5	s	s	PART
dpc-4332	70	6	,	,	PUNCT
dpc-4332	70	7	badiou	badiou	VERB
dpc-4332	70	8	c	c	NOUN
dpc-4332	70	9	,	,	PUNCT
dpc-4332	70	10	et	et	PROPN
dpc-4332	70	11	al	al	PROPN
dpc-4332	70	12	.	.	PROPN
dpc-4332	70	13	effect	effect	NOUN
dpc-4332	70	14	of	of	ADP
dpc-4332	70	15	antibiotics	antibiotic	NOUN
dpc-4332	70	16	on	on	ADP
dpc-4332	70	17	staphylococcus	staphylococcus	NOUN
dpc-4332	70	18	aureus	aureus	NOUN
dpc-4332	70	19	producing	produce	VERB
dpc-4332	70	20	panton	panton	PROPN
dpc-4332	70	21	-	-	PUNCT
dpc-4332	70	22	valentine	valentine	PROPN
dpc-4332	70	23	leukocidin	leukocidin	NOUN
dpc-4332	70	24	.	.	PUNCT
dpc-4332	71	1	antimicrob	antimicrob	PROPN
dpc-4332	71	2	agents	agents	PROPN
dpc-4332	71	3	chemother	chemother	PROPN
dpc-4332	71	4	.	.	PUNCT
dpc-4332	72	1	2007;51(4):1515	2007;51(4):1515	PROPN
dpc-4332	72	2	-	-	SYM
dpc-4332	72	3	1519	1519	NUM
dpc-4332	72	4	.	.	PUNCT
dpc-4332	73	1	doi:10.1128	doi:10.1128	NOUN
dpc-4332	73	2	/	/	SYM
dpc-4332	73	3	aac.01201	aac.01201	X
dpc-4332	73	4	-	-	SYM
dpc-4332	73	5	06	06	NUM
